Several Native tribes make COVID-19 vaccines available to everyone in Oklahoma
The Chickasaw, Choctaw, Osage, Cherokee, and Potawatomi nations are offering vaccinations to anyone in Oklahoma who needs one.
Public health & disease
Once-a-month PrEP pill shows promising results for HIV prevention
Islatravir, an HIV prevention drug developed by Merck, has already reached its second stage of trials. Following promising results, it looks likely to go to Phase 3 trials, bringing it one step closer to approval.
Ghana and Côte d’Ivoire begin history-making COVID vaccination drives
The West African nations each received more than half a million doses. The deliveries signify the launch of the largest, most rapid and complex global vaccine rollout in history, said WHO.
U.S. counties with more cannabis dispensaries are suffering fewer opioid deaths
A new study out of UC Davis suggests that increased access to cannabis stores that legally sell medical and recreational cannabis may help to reduce opioid-related deaths.
New prostate cancer test makes diagnosis in 20 minutes with near 100% accuracy
The breakthrough, developed by Korean scientists, is likely to revolutionize testing as existing methods are not only inaccurate but can result in over-diagnosis and necessitate invasive biopsies.
German scientists make paralyzed mice walk again
German researchers have enabled mice paralyzed after spinal cord injuries to walk again, re-establishing a neural link hitherto considered irreparable in mammals.
U.S. FDA approves first-ever long-acting HIV medication
The monthly injection treatment replaces the need for some to take daily pills. The company says the price of the injections is comparable to the cost of the pill versions.
Psychedelic research center launched at New York’s Mount Sinai
Named the Center for Psychedelic Psychotherapy and Trauma Research the institution is first focusing on MDMA-assisted psychotherapy for PTSD.
Vast majority of countries worldwide have achieved social progress since 2011
Progress has been made globally on eight of 12 key indicators. The Gambia, Nepal, Sierra Leone, Ethiopia and Tunisia shown particularly notable improvement.
U.N. reclassifies cannabis as a less dangerous drug
Cannabis is no longer classified as a Schedule IV drug as per WHO’s recommendation. The declassification opens up the door for more research into its medicinal and therapeutic uses.